Canada
· Delayed Price · Currency is CAD Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of CAD 9.90 million. The enterprise value is 9.28 million.
| Market Cap | 9.90M |
| Enterprise Value | 9.28M |
Important Dates
The next estimated earnings date is Monday, March 31, 2025.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +30.55% |
| Shares Change (QoQ) | +16.39% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 92.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 4.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.24 |
| EV / Sales | 4.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.01 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.12.
| Current Ratio | 0.98 |
| Quick Ratio | 0.94 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.10 |
| Interest Coverage | -10.09 |
Financial Efficiency
Return on equity (ROE) is -166.47% and return on invested capital (ROIC) is -64.06%.
| Return on Equity (ROE) | -166.47% |
| Return on Assets (ROA) | -44.29% |
| Return on Capital (ROIC) | -64.06% |
| Revenue Per Employee | 165,974 |
| Profits Per Employee | -319,236 |
| Employee Count | 13 |
| Asset Turnover | 0.45 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.16% in the last 52 weeks. The beta is 1.03, so Filament Health's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | -63.16% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 47.67 |
| Average Volume (20 Days) | 43,967 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.02 |
Income Statement
In the last 12 months, Filament Health had revenue of CAD 2.16 million and -4.15 million in losses. Loss per share was -0.02.
| Revenue | 2.16M |
| Gross Profit | 2.16M |
| Operating Income | -3.43M |
| Pretax Income | -4.15M |
| Net Income | -4.15M |
| EBITDA | -3.45M |
| EBIT | -3.43M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 878,717 in cash and 302,583 in debt, giving a net cash position of 576,134.
| Cash & Cash Equivalents | 878,717 |
| Total Debt | 302,583 |
| Net Cash | 576,134 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.49M |
| Book Value Per Share | 0.01 |
| Working Capital | -31,520 |
Cash Flow
In the last 12 months, operating cash flow was -3.03 million and capital expenditures -52,195, giving a free cash flow of -3.08 million.
| Operating Cash Flow | -3.03M |
| Capital Expenditures | -52,195 |
| Free Cash Flow | -3.08M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -158.74% and -192.34%.
| Gross Margin | 100.00% |
| Operating Margin | -158.74% |
| Pretax Margin | -192.34% |
| Profit Margin | -192.34% |
| EBITDA Margin | -159.85% |
| EBIT Margin | -158.74% |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.55% |
| Shareholder Yield | -30.55% |
| Earnings Yield | -51.91% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Filament Health has an Altman Z-Score of -7.02. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.02 |
| Piotroski F-Score | n/a |